Methods for the analysis of bleeding outcomes in randomized trials of PLT transfusion triggers

Transfusion

Volumn 44, Issue 8, 2004, Pages 1135-1142

  Cook, R J ^b   Heddle, Nancy M ^a   Rebuilla, P ^b   Sigouin, C S ^b   Webert, K E ^b  

^a MCMASTER UNIVERSITY   (Canada)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

BLEEDING; BLOOD TRANSFUSION; CANCER CLASSIFICATION; DATA ANALYSIS; HUMAN; LEUKEMIA; METHODOLOGY; PUBLICATION; REVIEW; SAFETY; STATISTICAL ANALYSIS; STATISTICS; THROMBOCYTE TRANSFUSION;

HEMORRHAGE; HUMANS; PLATELET TRANSFUSION; RANDOMIZED CONTROLLED TRIALS; RECURRENCE; RESEARCH DESIGN; TREATMENT OUTCOME;

EID: 3342880123     PISSN: 00411132     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1537-2995.2004.03231.x     Document Type: Review

References (31)

1. Rebulla P, Finazzi G, Marangoni F, et al. The threshold for prophylactic platelet transfusions in adults with acute myeloid leukemia. Gruppo Italiano Malattie Ematologiche Maligne dell'Adulto. N Engl J Med 1997;337:1870-5.
2. Heckman KD, Weiner GJ, Davis CS, et al. Randomized study of prophylactic platelet transfusion threshold during induction therapy for adult acute leukemia: 10,000/microL versus 20,000/microL. J Clin Oncol 1997;15:1143-9.
3. Meddle NM, Cook RJ, Rebulla P, et al. Bleeding as a clinical outcome in transfusion medicine trials: considerations and challenges. Transfusion 2003.
4. Gmur J, Burger J, Schanz U, et al. Safety of stringent prophylactic platelet transfusion policy for patients with acute leukaemia. Lancet 1991;338:1223-6.
5. Gil-Fernandez JJ, Alegre A, Fernandez-Villalta MJ, et al. Clinical results of a stringent policy on prophylactic platelet transfusion: non-randomized comparative analysis in 190 bone marrow transplant patients from a single institution. Bone Marrow Transplant 1996;18:931-5.
6. Navarro JT, Hernandez JA, Ribera JM, et al. Prophylactic platelet transfusion threshold during therapy for adult acute myeloid leukemia: 10,000/microL versus 20,000/microL. Haematologica 1998;83:998-1000.
7. Lawrence JB, Yomtovian RA, Hammons T, et al. Lowering the prophylactic platelet transfusion threshold: a prospective analysis. Leuk Lymphoma 2001;41:67-76.
8. 9/L trigger: a prospective comparative trial in 105 patients with acute myeloid leukemia. Blood 1998;91:3601-6.
9. Lee JJ, Hess KR, Dubin JA. Extensions and applications of event charts. The Am Statistician 2000;54:63-70.
10. Miller AB, Hoogstraten B, Staquet M, et al. Reporting results of cancer treatment. Cancer 1981;47:207-14.
11. Meddle NM. Evidence-based clinical reporting: a need for improvement. Transfusion 2002;42:1106-10.
12. Colton T. Controlled clinical trials. Am Rev Respir Dis 1974;110:20-4.
13. Laupacis A, Sackett DL, Roberts RS. An assessment of clinically useful measures of the consequences of treatment. N Engl J Med 1988;318:1728-33.
14. Sackett DL, Cook RJ. Understanding clinical trials. BMJ 1994;309:755-6.
15. Sackett DL, Haynes RB, Guyatt GH, Tugwell P, eds. Clinical epidemiology: a basic science for clinical medicine. Boston: Little Brown, 1991.
16. Matthews DE, Farewell VT, eds. Using and understanding medical statistics. New York: Karger, 1988.
17. Cox DR. Regression models and lifetimes (with discussion). J Royal Statist Soc Series B 1972;34:187-220.
18. Therneau TM, Grambsch PM. Modeling survival data: extending the Cox model. Springer, 2004.
19. Kalbfleisch JD, Prentice RL, eds. The statistical analysis of failure time data, 2nd ed. New York: John Wiley and Sons, 2002.
20. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Statist Assoc 1958;53:457-81.
21. Crowder M. Classical competing risks. Chapman and Hall, London, 2001.
22. Balakrishnan N, Rao CR. Handbook of statistics 23: Advances in survival analysis. Elsevier, London, 2004.
23. Gray RJ. A class of K-sample tests for comparing the cumulative incidence of a competing risk. Ann Stats 1988;16:1141-54.
24. Cook RJ, Major P. Methodology for treatment evaluation in patients with cancer metastatic to bone. J Natl Cancer Inst 2001;93:534-8.
25. Freedman L, Sylvester R, Byar DP. Using permutation tests and bootstrap confidence limits to analyze repeated events data from clinical trials. Control Clin Trials 1989;10:129-41.
26. Cook RJ, Lawless JF. Marginal analysis of recurrent events and a terminating event. Stat Med 1997;16:911-24.
27. Ghosh D, Lin DY. Nonparametric analysis of recurrent events and death. Biometrics 2000;56:554-62.
28. Cook RJ, Lawless JF, Nadeau C. Robust tests for treatment comparisons based on recurrent event responses. Biometrics 1996;52:557-71.
29. Andersen PK, Gill RD. Cox's regression model for counting processes: a large sample study. Ann Stats 1982;10:1100-20.
30. Willan AR, Chen EB, Cook RJ, et al. Incremental net benefit in randomized clinical trials with quality-adjusted survival. Stat Med 2003;22:353-62.
31. Rothmann M, Li N, Chen G, et al. Design and analysis of non-inferiority mortality trials in oncology. Stat Med 2003;22:239-64.